JAK2 and ovarian carcinoma: The ALKBH5-HOXA10 loop can mediate JAK2 m6 A demethylation and activate JAK2/STAT3 signaling pathway, facilitating cisplatin resistance in epithelial ovarian cancer (EOC) [260].